| Financial Year |
March 31 2023 |
| Monetary Funds |
641,318,933.21 |
| Held-for-trading Financial Assets |
682,393,823.02 |
| Notes Receivable |
20,736,342.65 |
| Accounts Receivable |
92,575,107.71 |
| Advances to Suppliers |
5,922,963.09 |
| Other Receivables |
10,143,902.84 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
112,399,346.60 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
6,945,373.61 |
| Total Current Assets |
1,587,705,730.21 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
-- |
| Fixed Assetes |
114,678,172.60 |
| Under-construction Projects |
116,308,076.63 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
39,358,700.52 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
328,468.75 |
| Deferred Income Tax Assets |
4,518,168.68 |
| Other Non-Current Assets |
12,322,733.84 |
| Sub-Total of Non-Current Assets |
289,452,327.23 |
| Total Assets |
1,877,158,057.44 |
| Short-Term Loans |
15,446,900.00 |
| Trading Financial liabilities |
-- |
| Notes Payable |
15,764,094.90 |
| Accounts Payable |
41,927,574.56 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
12,415,360.29 |
| Taxes Payable |
33,728,993.10 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
6,452,188.02 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
110,527.47 |
| Other Current Liabilities |
1,361,367.92 |
| Sub-Total of Current Liabilities |
137,679,067.19 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
2,532,480.02 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
3,398,383.22 |
| Total Liabilities |
141,077,450.41 |
| Paid-In Capital(Or Share Stock) |
133,333,334.00 |
| Capital Surplus |
1,087,817,790.96 |
| Surplus Reserve |
58,912,155.99 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
454,677,511.19 |
| Minority Stockholder's Interest |
-- |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,736,080,607.03 |
| Owner's Equity（Stockholder's Equity） |
1,736,080,607.03 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
1,877,158,057.44 |
